Brief: Acer Therapeutics Has Received Notice Of Delisting From Nasdaq
29/11/2022 22:20
Nov 29 (Reuters) - Acer Therapeutics Inc ACER.O :
* ON NOV 29, CO RECEIVED NOTICE OF DELISTING OR FAILURE TO
SATISFY
A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31